Larimar Therapeutics
LRMR
#8809
Rank
C$0.15 B
Marketcap
$2.48
Share price
-6.45%
Change (1 day)
-74.78%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.25

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.30. In 2022 the company made an earnings per share (EPS) of -$2.18 an increase over its 2021 EPS that were of -$4.20.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.25-42.87%
2022-$2.18-48.15%
2021-$4.20-14.27%
2020-$4.90